Common Shares Outstanding - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Common Shares Outstanding Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Common Shares Outstanding
zł23.1m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Common Shares Outstanding
zł6.2m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
2%
M
Medicofarma Biotech SA
WSE:MDB
Common Shares Outstanding
zł68m
CAGR 3-Years
116%
CAGR 5-Years
59%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Common Shares Outstanding
zł18.4m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Common Shares Outstanding?
Common Shares Outstanding
23.1m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Common Shares Outstanding amounts to 23.1m PLN.

What is Ryvu Therapeutics SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
8%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Ryvu Therapeutics SA have been 8% over the past three years , 8% over the past five years .

Back to Top